Tech Company Inital Public Offerings

Atossa Genetics IPO

On 11/8/2012, Atossa Genetics went public.

Transaction Overview

Company Name
Announced On
11/8/2012
Transaction Type
IPO
Amount
$4,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
107 Spring St.
Seattle, WA 98104
USA
Email Address
Not Recorded
Overview
Atossa Genetics is a healthcare company developing cellular and molecular diagnostic risk assessment products for breast cancer patients.
Profile
Atossa Genetics LinkedIn Company Profile
Social Media
Atossa Genetics Company Twitter Account
Company News
Atossa Genetics News
Facebook
Atossa Genetics on Facebook
YouTube
Atossa Genetics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Steven Quay
  Steven Quay LinkedIn Profile  Steven Quay Twitter Account  Steven Quay News  Steven Quay on Facebook
Chief Financial Officer
Kyle Guse
  Kyle Guse LinkedIn Profile  Kyle Guse Twitter Account  Kyle Guse News  Kyle Guse on Facebook
VP - Regulatory Affairs
Janet Rea
  Janet Rea LinkedIn Profile  Janet Rea Twitter Account  Janet Rea News  Janet Rea on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/8/2012: LearnStreet venture capital transaction
Next: 11/9/2012: Kinestral Technologies venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary